683 Capital Management, LLC — 13F Holdings & Portfolio
CIK 1404574 · latest 13F-HR filed 2026-08-14
683 Capital Management, LLC manages $2.04B in 13F-reported U.S. long-equity assets across 153 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PLTR (13.91%), LLY (9.07%), NVDA (4.48%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 19 new positions, exited 99, added to 47, and trimmed 34.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 4200
NEW YORK, NY 10019
$2.04B
Long-equity book
153
Distinct positions
2026-06-30
Filed 2026-08-14
+19 / −99 / ↑47 / ↓34
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- UNIQURE NV$18.3M +224.0%
- MOLINA HEALTHCARE INC$16.4M +76.9%
- ANAPTYSBIO INC$9.9M +28.5%
- MEIRAGTX HLDGS PLC$9.9M +46.5%
- LENNAR CORP$8.6M +1984.1%
Top Trims
- GXO LOGISTICS INCORPORATED-$15.0M -58.0%
- BARRICK MNG CORP-$7.4M -45.5%
- ASTRANA HEALTH INC-$7.4M -43.2%
- WAVE LIFE SCIENCES LTD-$6.8M -19.0%
- GRAPHIC PACKAGING HLDG CO-$4.5M -88.2%
New Positions
- UNITY SOFTWARE INC$17.6M
- FIRST TRACKS BIOTHERAPEUTICS$15.1M
- SEA LTD$12.9M
- HARMONY BIOSCIENCES HLDGS IN$10.7M
- NU HLDGS LTD$10.0M
Exited Positions
- ELI LILLY & CO$13.8M
- AMICUS THERAPEUTIC$11.2M
- GOSSAMER BIO INC$10.6M
- APELLIS PHARMACEUTICALS INC$10.1M
- LENNAR CORP$9.7M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PALANTIR TECHNOLOGIES INC Put | PLTR | 69608A108 | $283.4M | 13.91% | 2,428,700 | SH |
| 2 | ELI LILLY & CO Put | LLY | 532457108 | $184.7M | 9.07% | 154,000 | SH |
| 3 | NVIDIA CORPORATION Put | NVDA | 67066G104 | $91.2M | 4.48% | 456,000 | SH |
| 4 | SPDR SERIES TRUST Put | XBI | 78464A870 | $85.5M | 4.20% | 540,000 | SH |
| 5 | CAPITAL ONE FINL CORP | COF | 14040H105 | $73.2M | 3.60% | 365,000 | SH |
| 6 | ABBVIE INC Put | ABBV | 00287Y109 | $61.7M | 3.03% | 245,000 | SH |
| 7 | CARVANA CO | CVNA | 146869102 | $49.4M | 2.42% | 750,000 | SH |
| 8 | MADRIGAL PHARMACEUTICALS INC Put | MDGL | 558868105 | $48.3M | 2.37% | 90,000 | SH |
| 9 | ANAPTYSBIO INC | ANAB | 032724106 | $44.6M | 2.19% | 660,000 | SH |
| 10 | KASPI KZ JSC | KSPI | 48581R205 | $40.7M | 2.00% | 470,000 | SH |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 10806XAB8 | $38.8M | 1.90% | 21,750,000 | PRN |
| 12 | BECTON DICKINSON & CO | BDX | 075887109 | $37.8M | 1.86% | 250,000 | SH |
| 13 | MOLINA HEALTHCARE INC | MOH | 60855R100 | $37.7M | 1.85% | 165,000 | SH |
| 14 | PRAXIS PRECISION MEDICINES I Put | PRAX | 74006W207 | $37.0M | 1.82% | 110,400 | SH |
| 15 | HILTON GRAND VACATIONS INC | HGV | 43283X105 | $36.1M | 1.77% | 690,000 | SH |
| 16 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $35.5M | 1.75% | 290,000 | SH |
| 17 | ALNYLAM PHARMACEUTICALS INC Put | ALNY | 02043Q107 | $32.4M | 1.59% | 107,500 | SH |
| 18 | ARK ETF TR Put | ARKG | 00214Q302 | $31.5M | 1.55% | 750,000 | SH |
| 19 | MEIRAGTX HLDGS PLC | MGTX | G59665102 | $31.1M | 1.53% | 2,300,000 | SH |
| 20 | WAVE LIFE SCIENCES LTD | WVE | Y95308105 | $28.8M | 1.41% | 4,950,000 | SH |
| 21 | UNIQURE NV | QURE | N90064101 | $26.5M | 1.30% | 575,000 | SH |
| 22 | IONQ INC Put | IONQ | 46222L108 | $25.9M | 1.27% | 486,700 | SH |
| 23 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $23.0M | 1.13% | 1,279,512 | SH |
| 24 | AMENTUM HOLDINGS INC | AMTM | 023939101 | $22.7M | 1.12% | 1,100,000 | SH |
| 25 | TG THERAPEUTICS INC | TGTX | 88322Q108 | $21.4M | 1.05% | 389,081 | SH |
| 26 | PHATHOM PHARMACEUTICALS INC | PHAT | 71722W107 | $20.1M | 0.99% | 1,850,000 | SH |
| 27 | UNITY SOFTWARE INC | U | 91332U101 | $17.6M | 0.86% | 615,000 | SH |
| 28 | WESTERN ALLIANCE BANCORP | WAL | 957638109 | $16.4M | 0.81% | 200,000 | SH |
| 29 | IAMGOLD CORP | IAG | 450913108 | $16.0M | 0.79% | 1,010,000 | SH |
| 30 | ELEVANCE HEALTH INC FORMERLY | ELV | 036752103 | $15.5M | 0.76% | 40,000 | SH |
| 31 | FIRST TRACKS BIOTHERAPEUTICS | TRAX | 337185102 | $15.1M | 0.74% | 750,000 | SH |
| 32 | KNOT OFFSHORE PARTNERS LP | KNOP | Y48125101 | $15.0M | 0.74% | 1,505,000 | SH |
| 33 | UNIQURE NV Call | QURE | N90064101 | $14.6M | 0.72% | 316,200 | SH |
| 34 | SAREPTA THERAPEUTICS INC | SRPT | 803607100 | $14.1M | 0.69% | 782,500 | SH |
| 35 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $13.3M | 0.65% | 32,000 | SH |
| 36 | SEA LTD | SE | 81141R100 | $12.9M | 0.64% | 135,000 | SH |
| 37 | ALPHABET INC | GOOGL | 02079K305 | $12.5M | 0.61% | 35,000 | SH |
| 38 | ZEVRA THERAPEUTICS INC | ZVRA | 488445206 | $12.3M | 0.60% | 855,000 | SH |
| 39 | GENUINE PARTS CO | GPC | 372460105 | $11.9M | 0.59% | 101,000 | SH |
| 40 | ARIS MINING CORPORATION | ARIS | 04040Y109 | $11.5M | 0.56% | 770,000 | SH |
| 41 | INFLARX NV | IFRX | N44821101 | $11.3M | 0.56% | 5,065,000 | SH |
| 42 | COUPANG INC | CPNG | 22266T109 | $11.3M | 0.55% | 650,000 | SH |
| 43 | MODERNA INC Put | MRNA | 60770K107 | $10.9M | 0.54% | 156,000 | SH |
| 44 | GXO LOGISTICS INCORPORATED | GXO | 36262G101 | $10.9M | 0.54% | 215,000 | SH |
| 45 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 413197104 | $10.7M | 0.53% | 294,000 | SH |
| 46 | ALNYLAM PHARMACEUTICALS INC | ALNY | 02043Q107 | $10.5M | 0.52% | 35,000 | SH |
| 47 | NU HLDGS LTD | NU | G6683N103 | $10.0M | 0.49% | 750,000 | SH |
| 48 | HOWARD HUGHES HOLDINGS INC | HHH | 44267T102 | $10.0M | 0.49% | 140,000 | SH |
| 49 | ASTRANA HEALTH INC | ASTH | 03763A207 | $9.7M | 0.48% | 210,000 | SH |
| 50 | ENOVA INTL INC | ENVA | 29357K103 | $9.6M | 0.47% | 40,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $2.04B | 153 | 0001404574-26-000023 |
| 2026-03-31 | 2026-05-15 | $1.92B | 237 | 0001404574-26-000018 |
| 2025-12-31 | 2026-02-17 | $2.30B | 234 | 0001404574-26-000003 |
| 2025-09-30 | 2025-11-14 | $1.91B | 139 | 0001404574-25-000002 |